Tarsus Pharmaceuticals, Inc. TARS Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s preferred stock, par or stated value per share?
- Tarsus Pharmaceuticals, Inc. (TARS) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.